Genetics Flashcards
Grey platelet syndrome
NBEAL2, GFI 1B
AR
Wiskott Aldrich
WASP, X-linked
CD43
Bernard Soulier
GP1b/V/IX
GP1BB, GP1BA, GP9 genes
AR
Severe Congenital Neutropenia
SCN
Kostmann’s syndrome
ELANE
Hermansky Pudlak
HPS1, 1:1800 in Puerto Rico
Most are AR
Glanzmann Thrombasthenia
ITGA2B or ITGB3
AR
Chediak Higashi Syndrome
LYST
lysosomal storage issue, giant lysosomes and granules
AR
Polycythemia Vera
JAK2 V617F 95%
Jak2 Exon 12
Essential Thrombocytosis
JAK2 50-60%
CALR 30%
MPL 5-10%
Myelofibrosis
JAK2 50-60%
CALR 25%
MPL 5-10%
CML
BCR-ABL types
210 common
230 more mature neuts
190 ALL mostly
CML additional cytogenetic abnormalities
+ 8, 17, 19, 21
-7
i17q
3q26
11q23
Extra Ph+
Genetic predisposition syndromes, with thrombocytopenia
RUNX1
ANKRD26
ETV6
macrothrombocytopenias
MYH9
BSS
VWD2B
GATA1 [Xlinked]
Paris Trousseau [11q23 del]
Grey platelet
Congenital Amegakaryocytic thrombocytopenia [CAMT]
c-MPL gene
Thrombocytopenia absent radii
1q21 micerodeletion, RBM8A gene
RUSAT = radioulnar synostosis with amegakaryocytic thrombocytopenia
HOXA11 or MECOM
MECOM is AR and risk of myeloid malignancy and BMF
VWF gene and inheritance
VWF on 12p
Most Type 1 and 2 are AD
Type 3 AR, 2N AR
Thalassemia genes
alpha is 16
(4copies of alpha, 4x4 is 16)
beta is 11
Hb Variants
HbS: B chain 6th AA Glu->Val
HbC: Glu -> Lys
HbE: 26th AA Glu->Lys
Hb Lepore: crossover of beta and delta, so beta gene under delta promoter -> less beta -> like beta thal
Beta globin on chromosome 11
BMF syndrome genes
Fanconi: FANCA, FANCG, FANCC most AR
Telomeres: DKC1 [XL], TERC, TERT [AD]
GATA2: 3q21 [AD] variable phenotypes, MonoMAC syndrome
SAMD9/SAMD9L: 7q. Similar syndromes to GATA2. Can lose a 7 [del7] MDS or BMF and not be able to detect in heme cells
Anemia bone marrow failures
Diamond Blackfan: RPS19 [AD]
Congential dyserythropoietic anemia: 3 kinds, 2 is most common and treated with splenectomy, can look like HS
HH genetics
HFE gene on 6p: c282Y or H63D
HH type 2 [juvenile]: HJV [hemojuvulin] or HAMP [hepcidin]
TRF2 [transferrin receptor]
Hereditary Spherocytosis
Ankyrin [ANK1], Band 3 [SLC4A1], Spectrin [SPTB, SPTA1]
Hereditary Elliptocytosis, HPP
Spectrin [SPTB, SPTA], Protein 4.1
G6PD
X linked
4 Types, class 1 most severe
PK deficiency
PKLR gene, [AR], amish
Myelodysplasia related gene mutations
WHO5: SAS BEZUS
ICC: SARS BEZUS
(All end in 1 or 2 if number at end)
SF3B1
ASXL2
RUNX1
SRSF2
BCOR
EZH2
ZRSR2
U2AF1
STAG2
AML
MDS related Cytogenetic
WHO5
Complex 3+
-5q -7q -17p
-11q -12p -13q
isochron 17q
idic(X)q13
ICC
-5 -7 -17
-12 -20
i(17q)
+8
idic(X)q13
AML favourable risk by ELN 2022
t(8;21) RUNX1-RUNX1T1
inv(16) or t(16;16) CBFB-MYH11
NPM1 [without FLT3-ITD]
bZIP domain CEBPA
*inv(16) CBFA2B3-GLIS2 = RAM immunophenotype in paediatrics, and its bad
AML intermediate risk by ELN2022
any FLT3-ITD [unfavourable trumps]
t(9;11) MLLT3-KMT2A [any other t(v;11q23) is unfavourable]
Any other that’s not unfavourable or favourable
Other APL translocations
Which are resistant to ATRA?
Resistant to ATRA
t(11;17) ZBTB16:RARA
t(17;17) STAT5B:RARA
Transient abnormal myelopoiesis [TAM] or myeloid leukemia of down syndrome [ML-DS]
Morphology
Mutation
Megakaryoblastic
GATA1 mutation in both, with ML-DS acquire further other driver mutations
Leukemia predisposition:
1. Without a syndrome
2. Thrombocytopenia
3. With a syndrome
- CEBPA [m], DDX41 [m,l], TP53 [m,l]
- RUNX1 [m,l], ETV6 [m,l], ANKRD26 [m]
- GATA2, SAMD9/SAMD9L, Down Syndrome, BMF syndromes, Noonan’s, Bloom syndrome [biallelic BLM mut]
B-ALL recurrent genetic abnormalities
Translocations
ICC
t(9;22) BCR-ABL
t(4;11q23) 11q23 KMT2A
t(12;21) ETV6-RUNX1
t(5;14) IL3-IGH
t(1;19) TCF3-PBX1
WHO5
+TCF3-HLF fusion
B-ALL other genetic changes
Ploidy and genes
ICC
Hyperdiploid
Low Hypodiploid
Near haploid
BCR-ABL-like
iAMP21
IKZF1
MYC rearrangement
…many more
B-ALL, NOS
WHO5
Hyperdiploid
Hypodiploid
iAMP21
BCR-ABL like
+ ETV6-RUNX1 like
“other recurrent genetic abnormalities’
Good genetics in B-ALL?
Hyperdiploid
t(12;21) ETV6-RUNX1 [mostly kids age 2-10]
DUX4 rearrangements
Bad genetics in B-ALL
Hypodiploid
near haploid [24-31] worse
low hypo diploid [32-39] often TP53, 50% have germline TP53 [li fraumeni]
iAMP21 bad [get higher RUNX1]
11q23 KMT2A
TCF3 rearrangements [1;19] or [17;19]
IKZF1 - Ikaros or Ikaros-plus
T-ALL genetic abnormalities
Which are prognostic?
ICC
ETP-ALL with BCL11b mutation
ETP-ALL NOS
T-ALL, NOS
WHO5
T-ALL, NOS
ETP-ALL
Good:
Notch overexpression
HOX11A over expression
c-MYC rearrangements?
BAD: ETP-ALL
Is NK cell ALL a thing?
*NK cell ALL is now provisional entity in ICC
*NK cell ALL is fully removed from WHO5
Mature B cell ALL/Burkitts lymphoma/leukemia
Translocations
Chromosome 8 (c-MYC)
(8;14) MYC-IGH [most common]
(2;8) MYC-IGK [kappa]
(8;22) MYC-IGL [lambda]
B-ALL common in kids?
<1 yo and bad?
2-10 yo and good?
t(v;11q23) KMT2A rearranged = bad
50% of infants <1yo
t(12;21) ETV6-RUNX1 = good
Age 2-10 usually
Common other genes seen in MPN
TET2, ASXL1, DNMT3A, EZH2, IDH1, IDH2, SRSF2, U2AF1
Some MDS-associated, plus IDH, TET2
Genes in hereditary erythrocytosis
EPOR - EPO receptor
Oxygen sensing issues: VHL, HIF2alpha
Systemic Mastocytosis gene common
KIT D816V
activates KIT
90% of SM are +
Gives imatinib resistance
Can use Avapritinib [KIT inhibitor] or Midostaurin
Chronic Neutrophilic Leukemia [CNL] gene
CSF3R mutation
If +, get a point in diagnostic criteria and WBC only >13 for dx, is >25 if not CSF3R
Fusion driven hypereosinophilias
Myeloid/lymphoid neoplasms with tyrosine kinase gene fusions [TKGRs]
6
*PDGFRA [-FIP1L1]
*PDGFRB [-ETV6 or -FIP1L1]
FGFR1 rearrangement [not imatinib, maybe ponatinib or pemigatinib]
PCM1-JAK2
FLT3 fusions
*ABL1 fusions
*imatinib
ALL with high eosinophils?
t[5;14]
Neutrophil function disorders and gene/pathophys
- Chronic Granulomatous Disease - NADPH oxidase issue [NOX2]
- Chediak Higashi - LYST gene, lysosome issues
- Leukocyte Adhesion deficiency: can’t adhere to endothelium and migrate, or can’t phagocytose. Type 1: B2 integrin CD18 low, type 3 bleeds FERMT3
- MPO deficiency: in primary granules for microbe killing. Most asymptomatic, maybe more thrush
- High IgE/Job’s, STAT3 mutation, neutrophil chemotaxis issue
BRAF V600E mutation
Hairy cell leukemia
50% of Erdheim Chester disease
BRAF inhibitor = Vemurafenib
Genetic HLH
What inherited conditions result in HLH at end?
Most common trigger?
Perforin gene mutation [PRF1]
Immunodeficiencies like chediak higashi, grisellli, X-linked lymphoproliferative syndrome
EBV trigger in many genetic and acquired cases
EBV associated T cell lymphoma prone to HLH